<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Iran J Basic Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Iran J Basic Med Sci</journal-id><journal-title-group><journal-title>Iranian Journal of Basic Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">2008-3866</issn><issn pub-type="epub">2008-3874</issn><publisher><publisher-name>Mashhad University of Medical Sciences</publisher-name><publisher-loc>Iran</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28293400</article-id><article-id pub-id-type="pmc">5339664</article-id><article-id pub-id-type="publisher-id">IJBMS-20-216</article-id><article-id pub-id-type="doi">10.22038/ijbms.2017.8251</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Communication</subject></subj-group></article-categories><title-group><article-title>Gestational diabetes influences retinal Muller cells in rat&#x02019;s offspring</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tabasi</surname><given-names>Akramsadat</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ghafari</surname><given-names>Soraya</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Mehdizadeh</surname><given-names>Mehdi</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Shekari</surname><given-names>Majid Asadi</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Golalipour</surname><given-names>Mohammad Jafar</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Department of Anatomical Sciences, Golestan University of Medical Sciences, Gorgan, Iran</aff><aff id="aff2"><label>2</label>Gorgan Congenital Malformations Research Center, Department of Anatomical Sciences, Golestan University of Medical Sciences, Gorgan, Iran</aff><aff id="aff3"><label>3</label>Department of Anatomical Sciences, School of Medicine, Iran University of Medical Sciences, Tehran, Iran</aff><aff id="aff4"><label>4</label>Neuroscience Research Center, Neuropharmacology Institute. Kerman University of Medical Sciences, Kerman, Iran</aff><author-notes><corresp id="cor1"><label>*</label><italic>Corresponding author:</italic> Mohammad Jafar Golalipour. Gorgan Congenital Malformations Research Center, Department of Anatomical Sciences, Golestan University of Medical Sciences, Gorgan, Iran. Tel/Fax: +98-17- 32425165; email: <email xlink:href="mjgolalipour@yahoo.com">mjgolalipour@yahoo.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2017</year></pub-date><volume>20</volume><issue>2</issue><fpage>216</fpage><lpage>221</lpage><history><date date-type="received"><day>04</day><month>12</month><year>2016</year></date><date date-type="accepted"><day>20</day><month>10</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Iranian Journal of Basic Medical Sciences</copyright-statement><copyright-year>2017</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Objective(s):</title><p>The Muller cell is the principal glial cell of the vertebrate retina. The expression of Glial fibrillary acidic protein (GFAP) in the Muller cells was used as a cellular marker for retinal damage. This study was done to evaluate the effect of gestational diabetes on retinal Muller cells in rat&#x02019;s offspring.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>In this experimental study, 12 Wistar rat dams were randomly allocated in control and diabetic groups. Gestational diabetes was induced by 40 mg/kg/body weight of streptozotocin at the first day of gestation, intraperitoneally. Dams in control group received an equivalent volume normal saline. Eye of six offspring of each group were removed at postnatal day 28 (P28). The histopathological changes in retina were examined through H&#x00026;E staining and ultrastructure transmission electron microscopy (TEM). The expression of GFAP was examined using Immunohisto-chemical staining of GFAP in Muller cells. Photographs of retina were taken using Olympus BX51 microscope and a digital camera DP12 and EM LEO906; Zeiss, Germany.</p></sec><sec id="st3"><title>Results:</title><p>In the control rat&#x02019;s offspring, GFAP expression was not significant in Muller cells. According to the optical microscope images, GFAP expression was observed in the processes of the Muller cell in the inner plexiform layer of retina in offspring of diabetic mothers. In TEM technique, nuclear fragmentation and apoptotic bodies were observed in Muller cell of diabetic offspring.</p></sec><sec id="st4"><title>Conclusion:</title><p>This study showed that the uncontrolled gestational diabetes can increase GFAP expression in Muller cells and retinal thickness of retinal layer in rat offspring&#x02019;s, therefore uncontrolled gestational can damage the Muller cells.</p></sec></abstract><kwd-group><kwd>Gestational diabetes</kwd><kwd>GFAP</kwd><kwd>Mellitus</kwd><kwd>Muller cell</kwd><kwd>Retina</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>Introduction</title><p>Gestational Diabetes Mellitus (GDM) is the most common metabolic complications of pregnancy, and causes fetal mortality and morbidity (<xref rid="ref1" ref-type="bibr">1</xref>, <xref rid="ref2" ref-type="bibr">2</xref>). GDM is a state of glucose intolerance with the onset or first recognition occurring during pregnancy (<xref rid="ref3" ref-type="bibr">3</xref>) and approximately occurs in 2-5 % of all pregnancies (<xref rid="ref4" ref-type="bibr">4</xref>). Offspring of mothers with GDM are at increased risk for diabetes and obesity (<xref rid="ref5" ref-type="bibr">5</xref>, <xref rid="ref6" ref-type="bibr">6</xref>). The gestational diabetes prevalence is reported 1-3% in the United States, 10.9% in Asian countries, 5.2% in Europe (<xref rid="ref7" ref-type="bibr">7</xref>). A meta-analysis study indicated the prevalence of GDM ranged between 1.3% to 8.9% in different regions of Iran (<xref rid="ref8" ref-type="bibr">8</xref>).</p><p>Diabetes is associated with long-term complications that affect almost every part of the body, often leading to blindness, cardiovascular disease and kidney failure and nerve damage (<xref rid="ref9" ref-type="bibr">9</xref>). Long-term hyperglycemia causes irreversible pathological changes in the retina and leading to an increase in diabetic retinopathy (<xref rid="ref10" ref-type="bibr">10</xref>).</p><p>The decrease of retina ganglionic cell layer thickness in diabetes type 1 indicates that the retinal layers are mostly influenced by the effects of diabetes (<xref rid="ref11" ref-type="bibr">11</xref>). Diabetes-induced cell death has been observed in numerous retinal cell types such as endothelial cells and pericyte, neural retinal cells (ganglion cells) and retinal glial cells (Muller cells, astrocytes and microglia) (<xref rid="ref12" ref-type="bibr">12</xref>).</p><p>The Muller cell is the principal glial cell of the vertebrate retina; in the avascular retinae of many vertebrates (including mammals) it constitutes the only type of macroglial cells. Muller cells are specialized radial glial cells which span the entire thickness of the retina and contact/ensheath all retinal neuronal somata and their processes. Muller cells constitute an anatomical link between the retinal neurons and the compartments with which these need to exchange molecules, i. e., the retinal blood vessels, the vitreous body and the subretinal space (which, together with the retinal pigment epithelium (RPE), constitutes the pathway to the choroidal blood vessels) (<xref rid="ref13" ref-type="bibr">13</xref>). Retinal glial cells, primarily Muller glia change from quiescent to an injury-associated phenotype and express high levels of Glial fibrillary acidic protein (GFAP; a hallmark of glial cell activation) in the human retina during early diabetes (<xref rid="ref14" ref-type="bibr">14</xref>).</p><p>It has been reported that diabetes induces damage in avascular retinal neurons and Muller glial cells (<xref rid="ref11" ref-type="bibr">11</xref>, <xref rid="ref12" ref-type="bibr">12</xref>). Generally, the mammalian retina contains three types of glial cells. In addition to microglial cells, there are two forms of neuron-supporting macroglial cells, astrocytes and Muller (radial glial) cells (<xref rid="ref13" ref-type="bibr">13</xref>).</p><p>To assess astrocyte change, labeling experiments were performed on control and diabetic retinas using antibodies to GFAP a marker that labels retinal astrocytes but not Muller cells (<xref rid="ref15" ref-type="bibr">15</xref>, <xref rid="ref16" ref-type="bibr">16</xref>). Muller cells in the mammalian retina normally express low levels of glial fibrillary acidic protein (GFAP); however its expression is unregulated in response to the loss of retinal neurons. The change in expression of GFAP is one of the earliest indicators of retinal damage and is correlated with the time course of disease (<xref rid="ref17" ref-type="bibr">17</xref>).</p><p>GFAP expression in the retinas of the diabetic rats was also detected in the end feet of the Muller cells. In the retina of control rats, GFAP expression was limited to astrocytes and was not detected in Muller cells even at 40 weeks of follow-up. The expression of glial fibrillary acidic protein in Muller cells was used as a cellular marker for retinal damage (<xref rid="ref18" ref-type="bibr">18</xref>).</p><p>Diabetes induces abnormalities in retinal Muller cells, including increased expression of glial fibrillary acidic protein, reduction of glutamine syntheses and decreased function of glutamate transporter (<xref rid="ref19" ref-type="bibr">19</xref>).</p><p>Plasma cell membrane of retinal Muller glial cell has an important function in regulation volume through outward water transport. Recent studies indicated that retinal edema can be caused by swollen Muller glial cells following cell injury and upregulation of GFAP. Therefore, this study was done to determine the effect of induced gestational diabetes on the expression GFAP in Muller cells of retinal layer in rat&#x02019;s offspring (<xref rid="ref20" ref-type="bibr">20</xref>).</p><p>Also, a study has shown that the uncontrolled gestational diabetes can reduces the number of ganglionic neurons and increase apoptotic ganglionic cells of retina layer in rat offspring (<xref rid="ref21" ref-type="bibr">21</xref>).</p><p>Regarding the important role of Muller cell in supporting of neuronal retinal cell, this study was done to determine the effect of induced gestational diabetes on Muller cells of retinal layer in rat&#x02019;s offspring.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>Materials and Methods</title><p>This experimental study was performed at the Gorgan Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran. Guidelines on the care and use of laboratory animals and approval of the Ethics Committee of Golestan University of Medical Sciences were obtained before the study.</p><p>Wistar rats, weighing 180-220 g (12 weeks old) were used in this study. The animals were maintained in a climate-controlled room under a 12 hr alternating light/dark cycle, 20 &#x000b0;C to 25 &#x000b0;C temperature, and 50% to 55% relative humidity. Dry food pellets and water were provided <italic>ad libitum</italic>.</p><p>After 2 weeks of acclimation to the diet and the environment, female Wistar rats were placed with a proven breeder male overnight for breeding. Vaginal smears were done the next morning to check for the presence of sperm. Once sperm observed that day assigned as gestational day 0 (GD0). On day 1 of gestation, pregnant females randomly divided in two control and diabetic groups. Six female rats in diabetic group were received 40 mg/kg/body weight of streptozotocin (STZ) (Sigma, St Louis, MO, USA) dissolved in sterile saline solution (0.85%) and control group (six rats) were received an equivalent volume normal saline intraperitoneally (IP).</p><p>Blood glucose level of mothers (both before mating and 72 hr after STZ injection) was obtained via tail vein and was measured with a glucometer (ACCU-CHEK&#x000ae; Active Glucometer, Roche Diagnostics, Mannheim, Germany) (<xref rid="ref22" ref-type="bibr">22</xref>). The dams with blood glucose level 120-250 mg/dl were considered as gestational diabetes (<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref23" ref-type="bibr">23</xref>).</p><p>Six offspring of gestational diabetic mothers and control mothers in 28<sup>th</sup> day after birth (postnatal day 28) were randomly selected and were killed quickly with anesthesia. For light microscope preparations eyes were fixed in 10% neutral-buffered formalin and the tissue processing eyes sectioned at 6-micrometer thickness using a microtome (Microm HM 325, Germany).</p><p>Eye tissue sections were stained using hematoxylin &#x00026; eosin. For morphometric evaluation, 10-20 sections were observed with digital light microscopy. A photograph of sections was produced using an Olympus BX51 microscope and a DP12 digital camera. The density of Muller cells evaluated in 60000 &#x003bc;m<sup>2</sup> inner nucleus layer of eye and the thickness of inner retinal layer using OLYSIA Autobioreport software.</p><sec id="sec2-1"><title>Immunohistochemistry</title><p>Immunocytochemical labeling to detect the Muller cells was performed by monoclonal antibody anti GFAP (Millipore corporation Billerica, USA) on eye coronal sections with 6 &#x003bc;m thickness. In brief, deparaffinized sections were preincubated with citrate buffer and were washed for 9 min in 0.01 M phosphate-buffered saline (PBS, pH 7.4) and treated with 0.3% hydrogen peroxide in 0.01 M PBS including 10% methanol. The eye sections were preincubated with blocking reagent and washed in 0.01 M PBS. Then, eye sections were incubated with antiGFAP (1:600) in a humidified chamber for 1 hr at room temperature. After rinse in 0.01 M PBS, the sections were incubated with the biotinylated secondary for 10 min and then with Streptavidin HRP and rinsed in PBS. Immuno-reactivity was visualized using 3,3&#x02019; diaminobenzi-dine (DAB; chromogen reagent) for 30 min at room temperature. Subsequently, the tissue specimen was counterstained with Mayer&#x02019;s hematoxylin and mounted with Entellan (Merck, USA).</p></sec><sec id="sec2-2"><title>Electron microscopy technique</title><p>The eyes were removed and immersed in the fixative solution (250 ml of 4% paraformaldehyde, pH 7.4 at room temperature), overnight. A 400-&#x003bc;m block of area retina was dissected and fixed in buffered 2.5% glutaraldehyde for an additional 48 hr. Then the sections were washed in PBS solution and postfixed in 1% OSO<sub>4</sub> for 2 hr at room temperature. After dehydration in ascending graded ethanol, were embedded in Epon 812 resin. After that, they were put onto slices with resin and polymerized for 48 hr at 60 &#x000b0;C. Subsequently, 60 nm sections were cut and stained with 1% uranyl acetate and 2% lead citrate. Sections were examined with a Philips EM300 transmission electron microscope.</p></sec><sec id="sec2-3"><title>Statistical analysis</title><p>Statistical analysis was done by means of the statistical package SPSS 16. All data are given as mean &#x000b1;standard error of the mean (SEM). Comparisons between pairs of groups were carried out using Student&#x02019;s t test. Values of <italic>P</italic>&#x0003c;0.05 were considered to be statistically significant.</p></sec></sec><sec sec-type="results" id="sec1-3"><title>Results</title><sec id="sec2-4"><title>Blood glucose concentrations</title><p>The mean&#x000b1;SEM of blood glucose concentrations before mating and 72 hr after STZ injection were 100.42&#x000b1;2.1 and 211.60&#x000b1;6.30 mg/dl in diabetic dams. In control dams the mean&#x000b1;SEM of blood glucose concentrations before mating and 72 hr after STZ injection were 99.60&#x000b1;6.2 and 92.53&#x000b1;5.3 mg/dl, <xref ref-type="table" rid="T1">Table 1</xref>.</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>The mean&#x000b1;SEM of blood glucose level (mg/dl) in control and gestational diabetes dams in day 0 and day 3 after induction of diabetes</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Day</th><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">Gestational diabetes</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">GD0</td><td align="center" rowspan="1" colspan="1">99.60&#x000b1;6.2</td><td align="center" rowspan="1" colspan="1">100.42&#x000b1;2.1</td><td align="center" rowspan="1" colspan="1">NS</td></tr><tr><td align="left" rowspan="1" colspan="1">GD3</td><td align="center" rowspan="1" colspan="1">92.53&#x000b1;5.3</td><td align="center" rowspan="1" colspan="1">211.60&#x000b1;6.3</td><td align="center" rowspan="1" colspan="1"><xref ref-type="table-fn" rid="t1f1">*</xref> 0.001</td></tr></tbody></table><table-wrap-foot><fn><p>NS: Non significant,</p></fn><fn id="t1f1"><label>*</label><p><italic>P</italic>-value &#x0003c;0.05, n=6)</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec2-5"><title>Morphometric results</title><sec id="sec3-5"><title>Number of Muller cell processes</title><p>The number of Muller cell processes per 6000 &#x003bc;m<sup>2</sup> area of inner nucleus cell layer of retina were significantly increased in offspring of gestational diabetic mothers in comparison to controls (<italic>P</italic>&#x0003c;0.05) <xref ref-type="fig" rid="F1">Figure 1</xref>, <xref ref-type="table" rid="T2">Table 2</xref>.</p><fig id="F1" position="float"><label>Figuer 1</label><caption><p>Immunohistochemistry by monoclonal antibody anti GFAP of retinal layers in postnatal day 28 of Wistar rat. A) It is prominent in Muller cell inner processes in gestational diabetic retina, B) Control retina is GFAP negative (not shown). (ONL: outer nuclear layer, OPL: outer plexiform layer, INL: inner nuclear layer, IPL: inner plexiform layer, GCL: ganglionic cell layer, 1000X, Scale bar: 20 &#x000b5;m)</p></caption><graphic xlink:href="IJBMS-20-216-g001"/></fig><table-wrap id="T2" position="float"><label>Table 2</label><caption><p>The number of Muller cell processes and the thickness of retinal layer in postnatal day 28 of gestational diabetic and controls rat offspring</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics</th><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">Gestational diabetes</th><th align="center" rowspan="1" colspan="1"><italic>P</italic>-value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Number of Muller cell processes per (6000 &#x000b5;m<sup>2</sup>)</td><td align="center" rowspan="1" colspan="1">-</td><td align="center" rowspan="1" colspan="1">46.09&#x000b1;2.3</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.05<xref ref-type="table-fn" rid="t2f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Thickness of retinal layer (&#x000b5;m)</td><td align="center" rowspan="1" colspan="1">173.31&#x000b1;3.8</td><td align="center" rowspan="1" colspan="1">182.52&#x000b1;2.5</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.037<xref ref-type="table-fn" rid="t2f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Thickness of INL (&#x000b5;m)</td><td align="center" rowspan="1" colspan="1">26.36&#x000b1;0.93</td><td align="center" rowspan="1" colspan="1">29.89&#x000b1;0.46</td><td align="center" rowspan="1" colspan="1">&#x0003c;0.001<xref ref-type="table-fn" rid="t2f1">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>(Results were shown as mean&#x000b1;SEM,</p></fn><fn id="t2f1"><label>*</label><p><italic>P</italic>-value &#x0003c;0.05, n=6)</p></fn></table-wrap-foot></table-wrap></sec><sec id="sec3-1"><title>Retinal layer thickness</title><p>The thickness of INL significantly increased from 26.36&#x000b1;0.93 &#x003bc;m in the control group to 29.89&#x000b1;0.46 &#x003bc;m in the experimental group (<italic>P</italic>&#x0003c;0.001) and the thickness of retinal layer significantly increased from 173.31&#x000b1;3.8 mm in the control group to 182.52&#x000b1;2.5 &#x003bc;m in the gestational diabetic group (<italic>P</italic>&#x0003c;0.05), <xref ref-type="table" rid="T2">Table 2</xref>.</p></sec></sec><sec id="sec2-6"><title>Electron microscopy findings</title><p>Nuclear fragmentation and apoptotic bodies were observed in Muller cell of gestational diabetic offspring whereas control group showed normal structure by electron microscope, <xref ref-type="fig" rid="F2">Figure 2</xref>.</p><fig id="F2" position="float"><label>Figure 2</label><caption><p>Electron micrograph, Muller cells in the retina in postnatal day 28 (P28) of Wistar rat.</p><p>A) Gestational diabetes group showing nuclear fragmentation and apoptotic bodies in Muller cell. B) Normal structure in control group. 16000X (Scale bar: 750 nm)</p></caption><graphic xlink:href="IJBMS-20-216-g002"/></fig></sec></sec><sec sec-type="discussion" id="sec1-4"><title>Discussion</title><p>The focus of this article was the effect of gestational diabetes on retinal Muller cells. Muller cells are critically positioned between the vasculature and the neurons of the retina, has a important role in regulating the molecular composition of the retinal microenvironment (<xref rid="ref24" ref-type="bibr">24</xref>).</p><p>The main clinical lesion that is caused by diabetes in the retina are those of blood vessels, but evidence is also mounting that neural and glial cells of the retina are affected early in both human and experimental diabetes (<xref rid="ref21" ref-type="bibr">21</xref>, <xref rid="ref25" ref-type="bibr">25</xref>). The most prominent neuronal abnormality is apoptosis of cells whose size and location are consistent with ganglion cells (<xref rid="ref13" ref-type="bibr">13</xref>, <xref rid="ref21" ref-type="bibr">21</xref>). The glial alterations explained to date relate to the pattern and level of expression of GFAP. In diabetes, Muller cells acquire prominent GFAP immunoreactivity throughout the extension of their processes (<xref rid="ref26" ref-type="bibr">26</xref>).</p><p>This study showed that uncontrolled gestational diabetes increased expression of glial fibrillary acidic protein GFAP in the retinal Muller cells and retinal layer thickness of rat offspring.</p><p>Our finding is similar to several studies including Mizutani <italic>et al</italic> (1998), Ly <italic>et al</italic> (2011), Li <italic>et al</italic> (2001) and Mancini et al (2013), although these studies were done on diabetes type 1.</p><p>Mizutani <italic>et al</italic> (1998) study on human eyes from certified eye banks through the national disease research interchange showed that the level of GFAP was increased in the diabetic retinas (161&#x000b1;106 densitometric units/&#x000b5;g protein vs 55&#x000b1;45 in the nondiabetic retinas, <italic>P</italic>= 0.03) (<xref rid="ref16" ref-type="bibr">16</xref>).</p><p>Also, Li <italic>et al</italic> (2001) study in animal models using immunohistochemistry method by anti GFAP reported in the retinas from control rats, GFAP expression was limited to astrocyte. GFAP expression in the retinas of the diabetic rats was detected in the end feet of the Muller cells (<xref rid="ref27" ref-type="bibr">27</xref>).</p><p>Indeed, Ly <italic>et al</italic> (2011) study on rats retina using immunohistochemistry method by anti GFAP reported Muller cell were labeled for the GFAP after 4 and 6 weeks of diabetes. Muller cells in central retina display increased GFAP from 10 weeks of diabetes, whereas retinal occurs in the peripheral after 6 weeks of diabetes (<xref rid="ref28" ref-type="bibr">28</xref>).</p><p>Furthermore, Mancini <italic>et al</italic> (2013) study on two groups of Wistar rats injected with STZ two days after birth, reported in the two diabetic groups increased retinal immunoreactivity of GFAP in Muller cells but in the nondiabetic group GFAP expression was limited to astrocyte (<xref rid="ref29" ref-type="bibr">29</xref>).</p><p>In our study, we observed increased GFAP expression in stalk of Muller cells in inner nuclear layer of retina. The cytological changes observed in Muller cells in response to injury are accompanied by significant alteration in gene expression. Whereas proteins such as GFAP, glutamate/aspartate trans-porter (GLAST) are upregulatrd under phatological conditions. Other proteins appear to be down-regulated.</p><p>Immunocytochemical and <italic>in situ</italic> hybridization studies have shown GFAP is not expressed by Muller cells in embryonic or adult mouse retina, GFAP is integrated into Muller cell cytoskeleton and turns over extremely slowly or not at all. In contrast, GFAP mRNA is transcribed for a limited time and the gene is subsequently turned off. The increase in GFAP expression has been shown to be due to transcriptional activation of the GFAP gene in Muller cells. However, the cis and trans-activating factors that regulate GFAP gene expression in Muller cells have not been identified so far. Cell transfection and GFAP-lacZ transgenic mice studies indicate that cis elements that stimulate GFAP transcription in astrocytes and Muller cells are different. There is some evidence that growth factors and cytokines are the signaling molecules involved in GFAP induction.</p><p>Cellular mechanisms responsible for GFAP expression or mitotic activity in Muller cells: Molecules emanating from degenerating photoreceptors, and cytokines released from retinal compartments or secreted by activated macrophages, might act on Muller cells to induce GFAP expression or mitotic activity (<xref rid="ref30" ref-type="bibr">30</xref>). Also in this study nuclear fragmentation and apoptotic bodies were observed in Muller cell of gestational diabetic offspring compared with normal structure control group in electron microscope images. This study is similar to Kumar <italic>et al</italic> study they reported degenerated and swollen Muller cell processes in TEM ultramicrograph in diabetic group (<xref rid="ref31" ref-type="bibr">31</xref>).</p></sec><sec sec-type="conclusion" id="sec1-5"><title>Conclusion</title><p>We concluded that the uncontrolled gestational diabetes can increase GFAP expression and retinal layer thickness in Muller cells of retina layer in rat offspring. We suggested the babies born from mothers with gestational diabetes must be screened for retinal damage and dysfunction.</p></sec></body><back><ack><title>Acknowledgment</title><p>The study was supported by Gorgan Congenital Malformations Research Center and Deputy of Research of Golestan University of Medical Sciences, Gorgan, Iran (Grant number: 265727). The author&#x02019;s thanks from Neurosciences Research Center, Kerman University of Medical Sciences, Kerman, Iran.</p><p>This article is derived from thesis of Akramsadat Tabasi for MSc degree in field of anatomical sciences.</p></ack><ref-list><title>References</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Metzger</surname><given-names>BE</given-names></name><name><surname>Buchanan</surname><given-names>TA</given-names></name><name><surname>Coustan</surname><given-names>DR</given-names></name><name><surname>de Leiva</surname><given-names>A</given-names></name><name><surname>Dunger</surname><given-names>DB</given-names></name><name><surname>Hadden</surname><given-names>DR</given-names></name><etal/></person-group><article-title>Summary and recommendations of the fifth international workshop conference on gestational diabetes mellitus</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>251S</fpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jovanovic</surname><given-names>L</given-names></name><name><surname>Pettitt</surname><given-names>DJ</given-names></name></person-group><article-title>Gestational diabetes mellitus</article-title><source>JAMA</source><year>2001</year><volume>286</volume><fpage>2516</fpage><lpage>2518</lpage><pub-id pub-id-type="pmid">11722247</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>SY</given-names></name><name><surname>Callaghan</surname><given-names>WM</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Schmid</surname><given-names>CH</given-names></name><name><surname>Lau</surname><given-names>J</given-names></name><name><surname>England</surname><given-names>LJ</given-names></name><name><surname>Dietz</surname><given-names>PM</given-names></name></person-group><article-title>Maternal obesity and risk of gestational diabetes mellitus</article-title><source>Diabetes Care</source><year>2007</year><volume>30</volume><fpage>2070</fpage><lpage>2076</lpage><pub-id pub-id-type="pmid">17416786</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larijani</surname><given-names>B</given-names></name><name><surname>Hossein Nezhad</surname><given-names>A</given-names></name></person-group><article-title>Diabetes mellitus and pregnancy</article-title><source>Iran J Diabetes Lipid Dis</source><year>2002</year><volume>1</volume><fpage>9</fpage><lpage>22</lpage></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C</given-names></name><name><surname>Newton</surname><given-names>KM</given-names></name><name><surname>Knopp</surname><given-names>RH</given-names></name></person-group><article-title>Gestational diabetes and the incidence of type 2 diabetes</article-title><source>Diabetes Care</source><year>2002</year><volume>25</volume><fpage>1862</fpage><lpage>1868</lpage><pub-id pub-id-type="pmid">12351492</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><collab>American Diabetes Association</collab><article-title>Gestational Diabetes Mellitus</article-title><source>Diabetes Care</source><year>2004</year><volume>27</volume><fpage>S88</fpage><lpage>S90</lpage><pub-id pub-id-type="pmid">14693936</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coustan</surname><given-names>DR</given-names></name></person-group><article-title>Gestational diabetes mellitus</article-title><source>Clin Chem</source><year>2013</year><volume>59</volume><fpage>1310</fpage><lpage>1321</lpage><pub-id pub-id-type="pmid">23536513</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khoshnniat Nikoo</surname><given-names>M</given-names></name><name><surname>Abbaszadeh Ahranjani</surname><given-names>S</given-names></name><name><surname>Larijani</surname><given-names>B</given-names></name></person-group><article-title>A review on the prevalence of gestational diabetes mellitus (GDM) in different regions of Iran</article-title><source>Iran J Diabetes Lipid Dis</source><year>2009</year><volume>8</volume><fpage>47</fpage><lpage>56</lpage></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rakoczy</surname><given-names>EP</given-names></name><name><surname>Rahman</surname><given-names>IS</given-names></name><name><surname>Binz</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>CR</given-names></name><name><surname>Vagaja</surname><given-names>NN</given-names></name><name><surname>de Pinho</surname><given-names>M</given-names></name><name><surname>Lai</surname><given-names>CM</given-names></name></person-group><article-title>Characterization of a mouse model of hyperglycemia and retinal neovascularization</article-title><source>Am J Pathol</source><year>2010</year><volume>30</volume><issue>177</issue><fpage>2659</fpage><lpage>2670</lpage></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robinson</surname><given-names>R</given-names></name><name><surname>Barathi</surname><given-names>VA</given-names></name><name><surname>Chaurasia</surname><given-names>SS</given-names></name><name><surname>Wong</surname><given-names>TY</given-names></name><name><surname>Kern</surname><given-names>TS</given-names></name></person-group><article-title>Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals</article-title><source>Dis Mod Mech</source><year>2012</year><volume>5</volume><fpage>444</fpage><lpage>456</lpage></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Dijk</surname><given-names>HW</given-names></name><name><surname>Verbraak</surname><given-names>FD</given-names></name><name><surname>Kok</surname><given-names>PH</given-names></name><name><surname>Garvin</surname><given-names>MK</given-names></name><name><surname>Sonka</surname><given-names>M</given-names></name><name><surname>Lee</surname><given-names>K</given-names></name><etal/></person-group><article-title>Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes</article-title><source>Invest Ophthalmol Vis Sci</source><year>2010</year><volume>51</volume><fpage>3660</fpage><lpage>3665</lpage><pub-id pub-id-type="pmid">20130282</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feenstra</surname><given-names>DJ</given-names></name><name><surname>Yego</surname><given-names>EC</given-names></name><name><surname>Mohr</surname><given-names>S</given-names></name></person-group><article-title>Modes of retinal cell death in diabetic retinopathy</article-title><source>J Clin Exp Ophthalmol</source><year>2013</year><volume>4</volume><fpage>298</fpage><pub-id pub-id-type="pmid">24672740</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barber</surname><given-names>AJ</given-names></name></person-group><article-title>A new view of diabetic retinopathy: a neurodegenerative disease of the eye</article-title><source>Prog Neuro-psychopharmacol Biol Psychiatry</source><year>2003</year><volume>30</volume><issue>27</issue><fpage>283</fpage><lpage>290</lpage></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rungger-Brandle</surname><given-names>E</given-names></name><name><surname>Dosso</surname><given-names>AA</given-names></name><name><surname>Leuenberger</surname><given-names>PM</given-names></name></person-group><article-title>Glial reactivity, an early feature of diabetic retinopathy</article-title><source>Invest Ophthalmol Vis Sci</source><year>2000</year><volume>41</volume><fpage>1971</fpage><lpage>1980</lpage><pub-id pub-id-type="pmid">10845624</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bringmann</surname><given-names>A</given-names></name><name><surname>Pannicke</surname><given-names>T</given-names></name><name><surname>Grosche</surname><given-names>J</given-names></name><name><surname>Francke</surname><given-names>M</given-names></name><name><surname>Wiedemann</surname><given-names>P</given-names></name><name><surname>Skatchkov</surname><given-names>SN</given-names></name><name><surname>Osborne</surname><given-names>NN</given-names></name><name><surname>Reichenbach</surname><given-names>A</given-names></name></person-group><article-title>Muller cells in the healthy and diseased retina</article-title><source>Prog Retin Eye Res</source><year>2006</year><volume>25</volume><fpage>397</fpage><lpage>424</lpage><pub-id pub-id-type="pmid">16839797</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizutani</surname><given-names>M</given-names></name><name><surname>Gerhardinger</surname><given-names>C</given-names></name><name><surname>Lorenzi</surname><given-names>M</given-names></name></person-group><article-title>Muller cell changes in human diabetic retinopathy</article-title><source>Diabetes</source><year>1998</year><volume>47</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">9519752</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Downie</surname><given-names>LE</given-names></name><name><surname>Pianta</surname><given-names>MJ</given-names></name><name><surname>Vingrys</surname><given-names>AJ</given-names></name><name><surname>Wilkinson-Berka</surname><given-names>JL</given-names></name><name><surname>Fletcher</surname><given-names>EL</given-names></name></person-group><article-title>AT1 receptor inhibition prevents astrocyte degeneration and restores vascular growth in oxygen-induced retinopathy</article-title><source>Glia</source><year>2008</year><volume>56</volume><fpage>1076</fpage><lpage>1090</lpage><pub-id pub-id-type="pmid">18442090</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahs</surname><given-names>KR</given-names></name><name><surname>Kofuji</surname><given-names>P</given-names></name><name><surname>Meier</surname><given-names>C</given-names></name><name><surname>Dermietzel</surname><given-names>R</given-names></name></person-group><article-title>Connexin immunoreactivity in glial cells of the rat retina</article-title><source>J Comp Neurol</source><year>2003</year><volume>455</volume><fpage>531</fpage><lpage>546</lpage><pub-id pub-id-type="pmid">12508325</pub-id></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>XY</given-names></name><name><surname>Wang</surname><given-names>HZ</given-names></name><name><surname>Wang</surname><given-names>NL</given-names></name></person-group><article-title>Time course degeneration and expression of glial fibrillary acidic protein in mer-knockout mice</article-title><source>Chin Med J</source><year>2010</year><volume>123</volume><fpage>949</fpage><lpage>953</lpage><pub-id pub-id-type="pmid">20497693</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deeg</surname><given-names>CA</given-names></name><name><surname>Amann</surname><given-names>B</given-names></name><name><surname>Lutz</surname><given-names>K</given-names></name><name><surname>Hirmer</surname><given-names>S</given-names></name><name><surname>Lutterberg</surname><given-names>K</given-names></name><name><surname>Kremmer</surname><given-names>E</given-names></name><name><surname>Hauck</surname><given-names>SM</given-names></name></person-group><article-title>Aquaporin 11, a regulator of water efflux at retinal Muller glial cell surface decreases concomitant with immune-mediated gliosis</article-title><source>J Neuroinflamm</source><year>2016</year><volume>13</volume><fpage>89</fpage><lpage>100</lpage></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Najafdari</surname><given-names>S</given-names></name><name><surname>Rezaei</surname><given-names>N</given-names></name><name><surname>Malekzadeh Shafaroodi</surname><given-names>MM</given-names></name><name><surname>Ghafari</surname><given-names>S</given-names></name><name><surname>Golalipour</surname><given-names>MJ</given-names></name></person-group><article-title>Ganglionic cells apoptosis in retinal layer of rat offspring due to gestational diabetes</article-title><source>Int J Morphol</source><year>2014</year><volume>32</volume><fpage>1131</fpage><lpage>1135</lpage></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selvarajah</surname><given-names>D</given-names></name><name><surname>Tesfaye</surname><given-names>S</given-names></name></person-group><article-title>Central nervous system involvement in diabetes mellitus</article-title><source>Curr Diab Rep</source><year>2006</year><volume>6</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">17118225</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schoenle</surname><given-names>EJ</given-names></name><name><surname>Schoenle</surname><given-names>D</given-names></name><name><surname>Molinari</surname><given-names>L</given-names></name><name><surname>Largo</surname><given-names>RH</given-names></name></person-group><article-title>Impaired intellectual development in children with Type I diabetes: association with HbA(1c), age at diagnosis and sex</article-title><source>Diabetologia</source><year>2002</year><volume>45</volume><fpage>108</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">11845229</pub-id></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puro</surname><given-names>DG</given-names></name></person-group><article-title>Diabetes-induced dysfunction of retinal muller cells</article-title><source>Trans Am Ophthalmol Soc</source><year>2002</year><volume>100</volume><fpage>339</fpage><lpage>352</lpage><pub-id pub-id-type="pmid">12545700</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzi</surname><given-names>M</given-names></name><name><surname>Gerhardinger</surname><given-names>C</given-names></name></person-group><article-title>Early cellular and molecular changes induced by diabetes in the retina</article-title><source>Diabetologia</source><year>2001</year><volume>44</volume><fpage>791</fpage><lpage>804</lpage></element-citation></ref><ref id="ref26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asnaghi</surname><given-names>V</given-names></name><name><surname>Gerhardinger</surname><given-names>Ch</given-names></name><name><surname>Hoehn</surname><given-names>T</given-names></name><name><surname>Adeboje</surname><given-names>A</given-names></name><name><surname>Lorenzi</surname><given-names>M</given-names></name></person-group><article-title>A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>506</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">12540628</pub-id></element-citation></ref><ref id="ref27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Zemel</surname><given-names>E</given-names></name><name><surname>Miller</surname><given-names>B</given-names></name><name><surname>Perlman</surname><given-names>I</given-names></name></person-group><article-title>Early retinal damage in experimental diabetes: electroretinographical and morphological observations</article-title><source>Exp Eye Res</source><year>2002</year><volume>74</volume><fpage>615</fpage><lpage>625</lpage><pub-id pub-id-type="pmid">12076083</pub-id></element-citation></ref><ref id="ref28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ly</surname><given-names>A</given-names></name><name><surname>Yee</surname><given-names>P</given-names></name><name><surname>Vessey</surname><given-names>KA</given-names></name><name><surname>Phipps</surname><given-names>JA</given-names></name><name><surname>Jobling</surname><given-names>AI</given-names></name><name><surname>Fletcher</surname><given-names>EL</given-names></name></person-group><article-title>Early inner retinal astrocyte dysfunction during diabetes and development of hypoxia, retinal stress, and neuronal functional loss</article-title><source>Invest Ophthalmol Vis Sci</source><year>2011</year><volume>52</volume><fpage>9316</fpage><lpage>9326</lpage><pub-id pub-id-type="pmid">22110070</pub-id></element-citation></ref><ref id="ref29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mancini</surname><given-names>JE</given-names></name><name><surname>Ortiz</surname><given-names>G</given-names></name><name><surname>Croxatto</surname><given-names>JO</given-names></name><name><surname>Gallo</surname><given-names>JE</given-names></name></person-group><article-title>Retinal upregulation of inflammatory and proangiogenic markers in a model of neonatal diabetic rats fed on a high-fat-diet</article-title><source>BMC Ophthalmol</source><year>2013</year><volume>13</volume><fpage>14</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">23587252</pub-id></element-citation></ref><ref id="ref30"><label>30</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Sarthy</surname><given-names>V</given-names></name><name><surname>Ripps</surname><given-names>H</given-names></name></person-group><source>The retinal Muller cell: structure and function</source><year>2001</year><publisher-loc>New York</publisher-loc><publisher-name>Springer Science &#x00026; Business Media</publisher-name></element-citation></ref><ref id="ref31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>B</given-names></name><name><surname>Gupta</surname><given-names>SK</given-names></name><name><surname>Srinivasan</surname><given-names>BP</given-names></name><name><surname>Nag</surname><given-names>TC</given-names></name><name><surname>Srivastava</surname><given-names>S</given-names></name><name><surname>Saxena</surname><given-names>R</given-names></name><name><surname>Jha</surname><given-names>KA</given-names></name></person-group><article-title>Hesperetin rescues retinal oxidative stress, neuroinflammation and apoptosis in diabetic rats</article-title><source>Microvasc Res</source><year>2013</year><volume>87</volume><fpage>65</fpage><lpage>74</lpage><pub-id pub-id-type="pmid">23376836</pub-id></element-citation></ref></ref-list></back></article>